Understand GLP-1 and dual-incretin medicines through clear product profiles, safety guidance, and carefully sourced research.
Peptides are short chains of amino acids that can act as precise messengers in the body. Modern incretin medicines build on those signals to influence appetite, food intake, and metabolic regulation.
How GLP-1 medicines workEach profile separates active ingredient, approved product, administration schedule, evidence, and important safety context.
Catalog profile for Lipo-c in the supplied format 10 mL × 10vials, identified by source SKU LC216.
Catalog profile for B12 in the supplied format 10 mg × 10vials, identified by source SKU B12.
Catalog profile for HCG in the supplied format 5000 IU × 10vials, identified by source SKU G5K.
Good treatment decisions are a process, not a product ranking.
Learn what GLP-1, GIP, and peptide signaling mean in plain language.
Check the active ingredient, approved brand, indication, and formulation.
Bring history, medications, goals, and questions to a licensed clinician.
Track tolerability, function, nutrition, and follow-up, not only weight.
Peptide medicines depend on controlled synthesis, formulation, filling, storage, and inspection. That is why an approved product and an unknown online vial are not equivalent categories.
Read about safety, lifestyle support, clinical trials, and the questions worth taking to your next appointment.
A investigative performance and endocrine risk file review of Melanotan II, focused on identity record, source quality and evidence boundaries.
A investigative performance and endocrine risk file review of Melanotan I, focused on identity record, source quality and evidence boundaries.
A investigative performance and endocrine risk file review of SLU-PP-332, focused on identity record, source quality and evidence boundaries.
A investigative performance and endocrine risk file review of HCG, focused on identity record, source quality and evidence boundaries.
A investigative performance and endocrine risk file review of B12, focused on identity record, source quality and evidence boundaries.
A investigative performance and endocrine risk file review of Lipo-c, focused on identity record, source quality and evidence boundaries.
Clinical evidence, medication safety, and nutrition guidance are reviewed by contributors with clear roles and biographies.
Meet the editorial team